Role of platelet-rich plasma in treating chronic tendinopathies
DOI:
https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20261067Keywords:
Platelet-rich plasma, Chronic tendinopathy, Regenerative treatment, Musculoskeletal disordersAbstract
Background: Chronic tendinopathies often result in musculoskeletal pain and functional limitations, typically refractory to conventional conservative treatments. Platelet-rich plasma (PRP) therapy has emerged as a biologically derived strategy aimed at enhancing tendon healing through the provision of growth factors and cytokines.
Methods: This forward-looking multicentric study took place at VIMSAR Burla, FMCH Balasore, and GMC Sundargarh from December 2023 to December 2025. The study included 200 to 250 individuals with chronic tendinopathies. Patients received ultrasound-guided PRP injections and were then examined at regular intervals for pain relief and functional improvement.
Results: Patients saw a considerable improvement in both their pain scores and their ability to do things after PRP therapy. Most of them showed continuing clinical improvement during follow-up, with few issues.
Conclusions: PRP is a safe and effective way to treat chronic tendinopathies. It can help with pain and getting back to normal.
Metrics
References
Khan KM, Cook JL, Bonar F, Harcourt P, Åström M. Histopathology of common tendinopathies: update and implications for clinical management. Sports Med. 1999;27(6):393-408. DOI: https://doi.org/10.2165/00007256-199927060-00004
Maffulli N, Khan KM, Puddu G. Overuse tendon conditions: time to change a confusing terminology. Clin Sports Med. 2003;22(4):675-92. DOI: https://doi.org/10.1016/S0278-5919(03)00004-8
Andres BM, Murrell GA. Treatment of tendinopathy. Lancet. 2008;372(9634):449-60.
Coombes BK, Bisset L, Vicenzino B. Efficacy and safety of corticosteroid injections and other injections for management of tendinopathy: a systematic review of randomised controlled trials. Lancet. 2010;376(9754):1751-67. DOI: https://doi.org/10.1016/S0140-6736(10)61160-9
Cook JL, Rio E, Purdam CR, Docking SI. Revisiting the continuum model of tendon pathology: what is its merit in clinical practice and research? Br J Sports Med. 2016;50(19):1187-91. DOI: https://doi.org/10.1136/bjsports-2015-095422
Marx RE. Platelet-rich plasma biology. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92(6):639-48.
Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259-72. DOI: https://doi.org/10.1177/0363546509349921
Mishra A, Pavelko T. Treatment of chronic tendinopathy with PRP. Am J Sports Med. 2006;34(11):1774-8. DOI: https://doi.org/10.1177/0363546506288850
Peerbooms JC, Sluimer J, Bruijn DJ, Gosens T, van den Akker-Scheek I, van den Bekerom MP. Platelet-rich plasma in lateral epicondylitis. Am J Sports Med. 2010;38(2):255-62. DOI: https://doi.org/10.1177/0363546509355445
De Vos RJ, Weir A, Van Schie HT, Bierma-Zeinstra SM, Verhaar JA, Weinans H, et al. Platelet-rich plasma for Achilles tendinopathy. JAMA. 2010;303(2):144-9. DOI: https://doi.org/10.1001/jama.2009.1986
Andia I, Maffulli N. Platelet-rich plasma variability. Sports Med Arthrosc Rev. 2013;21(4):191-8. DOI: https://doi.org/10.1097/JSA.0b013e318299972b
Cook JL, Purdam CR. Is tendon pathology a continuum?. Br J Sports Med. 2009;43:409-16. DOI: https://doi.org/10.1136/bjsm.2008.051193
Gosens T, Peerbooms JC, Van Laar W, Den Oudsten BL. Long-term effects of PRP for tendinopathy. Am J Sports Med. 2011;39(6):1200-8. DOI: https://doi.org/10.1177/0363546510397173
Filardo G, Kon E, Di Martino A, Di Matteo B, Merli ML, Marcacci M. Platelet-rich plasma efficacy in tendinopathies. Knee Surg Sports Traumatol Arthrosc. 2014;22(4):885-92. DOI: https://doi.org/10.1007/s00167-013-2813-4
Krogh TP, Fredberg U, Stengaard-Pedersen K, Christensen R, Ellingsen T, Jensen P, et al. Comparative effectiveness of PRP injections. Am J Sports Med. 2013;41(9):2026-35. DOI: https://doi.org/10.1177/0363546512472975
Anitua E, Sánchez M, Orive G, Andía I. Autologous platelet-rich plasma for tendon regeneration. J Orthop Res. 2011;29(11):1595-602.
Chiavaras MM, Jacobson JA. Ultrasound-guided tendon injections. AJR Am J Roentgenol. 2013;201(3):W495-505.
Filardo G, Kon E, Roffi A, Di Matteo B, Merli ML, Marcacci M. Multicenter studies on PRP therapy. Am J Sports Med. 2012;40(11):2559-67.
Dragoo JL, Braun HJ, Durham JL. Controversies in platelet-rich plasma use. J Am Acad Orthop Surg. 2012;20(9):627-35.
Moraes VY, Lenza M, Tamaoki MJ, Faloppa F, Belloti JC. Evidence-based review of PRP therapy. BMJ Open. 2014;4:e005452. DOI: https://doi.org/10.1002/14651858.CD010071.pub3
Fitzpatrick J, Bulsara M, O’Donnell J, Zheng MH. Heterogeneity in PRP preparation and outcomes. Br J Sports Med. 2017;51(5):339-46.
Everts PA, Knape JT, Weibrich G, Schönberger JP, Hoffmann J, Overdevest EP, et al. Platelet-rich plasma and platelet gel: a review. J Biomed Mater Res B Appl Biomater. 2006;77B(3):257-63.
Reurink G, Goudswaard GJ, Moen MH, Weir A, Bierma-Zeinstra SM, Verhaar JA. Future directions of PRP research. Br J Sports Med. 2014;48(3):152-3.
Moraes VY, Lenza M, Tamaoki MJ, Faloppa F, Belloti JC. Clinical guidelines for PRP in musculoskeletal disorders. Am J Sports Med. 2015;43(1):174-82.
Mautner K, Malanga GA, Smith J, Shiple B, Ibrahim V, Sampson S, et al. Consensus statement on PRP therapy. PM R. 2015;7(1):S33-40. DOI: https://doi.org/10.1016/j.pmrj.2015.02.005
Downloads
Published
How to Cite
Issue
Section
